AI Verdict
PUBM has stronger fundamentals based on our AI analysis.
PUBM vs PTIXW Fundamental Comparison
| Metric | PUBM | PTIXW |
|---|---|---|
| Revenue | $282.9M | $0.0 |
| Net Income | $-14.5M | $-3.7M |
| Net Margin | -5.1% | N/A |
| ROE | -5.5% | N/A |
| ROA | -2.1% | -83.9% |
| Current Ratio | 1.39x | 0.34x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-0.31 | $-1.50 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PUBM vs PTIXW: Frequently Asked Questions
Is PUBM or PTIXW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PUBM has stronger fundamentals. PUBM is rated HOLD (72% confidence) while PTIXW is rated STRONG SELL (88% confidence). This is not investment advice.
How does PUBM compare to PTIXW fundamentally?
PubMatic, Inc. has ROE of -5.5% vs Protagenic Therapeutics, Inc.new's N/A. Net margins are -5.1% vs N/A respectively.
Which stock pays higher dividends, PUBM or PTIXW?
PUBM has a dividend yield of N/A or no dividend while PTIXW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PUBM or PTIXW for long term?
For long-term investing, consider that PUBM has HOLD rating with 72% confidence, while PTIXW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PUBM vs PTIXW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PUBM vs PTIXW, the AI consensus favors PUBM based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.